Responding to the consultation on the draft 2011 fees rules for the General Pharmaceutical Council, the National Pharmacy Boards have expressed concern about the lack of data presented by the GPhC to explain the fees they have set.
Asthma UK has criticised NICE’s decision not to recommend a pioneering medicine which could help hundreds of children in England.
Omalizumab, brand name Xolair, is used as a treatment for severe persistent allergic asthma. However, NICE decided against recommending it for use with children aged 6-11 years because evidence highlighted little extra benefit compared with existing treatments for this age
Boots UK has announced the launch of a new online private prescription service, which allows customers to have their medications delivered directly to a personal address, their place of work or a selected Boots store.
‘Prescriptions Direct’ will be managed by specially trained healthcare professionals. Customers register online and complete a confidential questionnaire. Next their request is assessed by the Boots
The NPA has said that a lot more needs to be done to tackle medicines waste if the health service is to start making significant savings.
The pharmacy trade association made the comments on 9th August in response to recent guidance which has asked GPs to revise prescribing “in the context of a challenging medium term financial position”.
The new recommendations were
The RPSGB today announced the appointment of Alex MacKinnon as Director for Scotland. Mr MacKinnon is currently Head of Corporate Affairs at Community Pharmacy Scotland, where he has worked in a variety of high profile roles since 2005.
Prior to this he held roles within Lloydspharmacy and originally qualified as a community pharmacist in 1975. He will lead the Society’s